Author:
Sanjay Srinivasan,Acharya Isha,Rawoof Abdul,Shetty Rohit
Abstract
A woman in her 50s presented with diminution of vision in her left eye (OS) 4 days after COVISHIELDTMvaccination. She had been diagnosed with non-arteritic anterior ischaemic optic neuropathy (NA-AION) of right eye (OD) 8 months earlier. The present episode revealed a best-corrected visual acuity (BCVA) of 20/50 in OD and 20/20 in OS with grade 1 relative afferent pupillary defect. Fundus evaluation showed pale disc in OD and temporal disc oedema in OS. Humphrey’s visual field analysis showed incomplete inferior altitudinal defect in OD and a centro-caecal scotoma in OS. Systemic investigations were normal. OS was diagnosed with NA-AION. She was started on oral aspirin 75 mg. At 1-month follow-up, disc oedema of OS had resolved with BCVA maintaining at 20/20. The patient was lost to follow-up later. The relationship between the vaccine and the ocular event is temporal with no causal association.
Reference51 articles.
1. The impact of COVID-19 on global health goals, 2021. Available: https://www.who.int/news-room/spotlight/the-impact-of-covid-19-on-global-health-goals [Accessed 21 Jan 2022].
2. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in abu dhabi;Pichi;JAMA Ophthalmol,2021
3. Bilateral multifocal choroiditis following COVID-19 vaccination;Goyal;Ocul Immunol Inflamm,2021
4. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine;Koong;Ocul Immunol Inflamm,2021
5. Acute-Onset central serous retinopathy after immunization with COVID-19 mRNA vaccine;Fowler;Am J Ophthalmol Case Rep,2021
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献